Daily Stock List
Medizone International, Inc. (MZEI)
TopPennyStockMovers, PennyStocks24, Stock Brain, HEROSTOCKS, VIP STOCK ALERTS, Stockhunter.us, and Liquid Pennies reported on Medizone International, Inc. (MZEI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Medizone International, Inc. and its’ subsidiaries have been a development stage company conducting research into the use of ozone in the disinfection of surgical and other medical treatment facilities and in other applications. During 2012, the Company emerged from the development stage. It started to sell its patented ozone disinfection system, AsepticSure®. Medizone International is headquartered in Sausalito, California, and the Company lists on the OTC Bulletin Board.
Medizone International’s BSL2A certified laboratory is at Innovation Park, Queen’s University in Kingston, Ontario. It provides a primary research and development platform for the Company.
The AsepticSure® hospital sterilization system is a portable, affordable, easily operated system. It can be used by trained maintenance staff and it is placed in the center of the room to be cleaned. Vents and doors are then sealed with an easily and cleanly removable 3M-tape product.
The system is turned on from outside of the room via a remote wireless computer interface. The room is filled with a unique and patented gas formula, which is ozone-based to specific humidity and charge strength. The sterilization process is remotely turned off after the charge period and a separate technology is utilized that restores the atmosphere inside the room to Environmental Protection Agency (EPA) standards.
After December 31, 2012, Singapore issued Medizone International its Health Care Patent. The Company considers this significant for its business growth in Asia. The medical system in Singapore looks to distinguish itself with the safest hospitals possible to promote continued growth in the expanding medical tourism market.
Recently, Medizone International announced that the same biological indicators used to confirm medical instrument sterilization in autoclaves, may also be used to confirm absolute bactericidal kill for hospital room disinfection. Spore test strips have now become the reference standard for routine quality assurance of hospital instrument sterilization.
According to the FDA, they should be used with each autoclave load. In laboratory testing, Medizone has discovered that the same spore test strips are completely inactivated (killed) when placed in a room during an AsepticSure run.
Medizone International, Inc. (MZEI), closed Tuesday's trading session at $0.12, up 2.13%, on 68,710 volume with 12 trades. The average volume for the last 60 days is 156,273 and the stock's 52-week low/high is $0.0701/$0.22.
RegeneRx Biopharmaceuticals, Inc. (RGRX)
TopPennyStockMovers and SmarTrend Newsletters reported on RegeneRx Biopharmaceuticals, Inc. (RGRX), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Rockville, Maryland-based RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company. It concentrates on tissue protection, repair and regeneration with a wide-ranging portfolio of product candidates for first-in-class therapeutic peptides. The Company’s mission is to research and develop novel pharmaceuticals, which protect and repair tissue and organ damage caused by disease, trauma or other pathology. RegeneRx Biopharmaceuticals lists on the OTC Markets’ OTCQB.
RegeneRx holds multiple issued patents or filed patent applications globally to enable and protect multiple indications and applications for its product candidates. The Company currently has three drug candidates in clinical development for ophthalmic, cardiac, and dermal indications. Additionally, it has three active strategic licensing agreements in China, Pan Asia (Korea, Japan, and Australia, among others) and the U.S. and has a broad worldwide patent portfolio covering its products.
RegeneRx is focusing on the development of Thymosin beta 4 (a novel therapeutic peptide), for tissue and organ protection, repair and regeneration. RGN-259, its TB4-based ophthalmic drug candidate, has been designated an orphan drug for the treatment of neurotrophic keratopathy (NK), which is a principal focus of RegeneRx's clinical development efforts in the U.S.
RegeneRx was recently allowed by the Food and Drug Administration (FDA) to move into Phase III clinical trials with RGN-259 for the treatment of patients with neurotrophic keratopathy (NK). RGN-259 is a Tβ4-based sterile eye drop. The Company is developing this as a novel treatment for corneal healing.
The RGN-259 drug candidate is also being studied in patients with dry eye syndrome in the U.S. and Asia. RegeneRx, via its U.S. joint venture, ReGenTree LLC, is developing RGN-259 in the U.S. and expects to initiate a Phase IIb/III trial later in 2015.
The Company’s management team is centering on moving three distinct Tβ4-based drug candidates through the clinic. These are RGN-137, the above-mentioned RGN-259 and RGN-352. RGN-137 is a topical gel formulation of the peptide Tβ4. RegeneRx is developing this as a novel treatment to hasten dermal healing.
In addition, RegeneRx is developing RGN-352. RGN-352 is its TB4-based injectable. This is a Phase 2-ready drug candidate designed to be administered systemically to prevent and restore tissue damage associated with acute events. This includes heart attacks, strokes, and other similar traumatic injuries.
In June, RegeneRx Biopharmaceuticals announced a peer-reviewed publication of the results of a recent cardiac stem cell clinical trial, which demonstrates the potentially key role that Thymosin beta 4 (TB4) plays in the functional repair of cardiovascular disease. The clinical trial demonstrated elevated Thymosin Beta 4 plasma levels are associated with improvement of symptoms after stem cell therapy in patients with ischemic heart failure. Functional improvement six months after heart attack correlated with higher TB4 levels.
RegeneRx Biopharmaceuticals, Inc. (RGRX), closed Tuesday's trading session at $0.34, down 2.02%, on 38,876 volume with 24 trades. The average volume for the last 60 days is 120,935 and the stock's 52-week low/high is $0.1005/$0.60.
Praxsyn Corp. (PXYN)
Profit Status, Information Solutions Group, EmergingStockPlays, StockPickVIP, OtcShortReport, Pennystocktweeters.com, Impressive Penny Stocks, OTCMagic, Winston Small Cap, Penny Stock Circle, and Bull Trends reported earlier on Praxsyn Corp. (PXYN), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Irvine, California-based Praxsyn Corp. concentrates on providing custom compounded non-narcotic, transdermal topical pain medications to industrial health physicians and clinics. At present, the Company formulates transdermal creams in its compounding pharmacy, Mesa Pharmacy. It has developed a series of topical ointments for pain relief. Praxsyn is working on establishing its Point of Care/In-Office Dispensing Program, and its’ In-Office Toxicology Testing. NexGen Med Solutions, LLC is a wholly-owned subsidiary of Praxsyn. Praxsyn lists on the OTC Markets Group’s OTCQB.
Praxsyn’s Point-Of-Care Services will provide the health care provider with pharmaceuticals and testing services that are convenient and easy for physicians and staff. Its wholly-owned subsidiary, Mesa Pharmacy, Inc., provides doctors with an alternative to oral pain medications. Mesa Pharmacy focuses on providing custom compounded non-narcotic, transdermal topical pain medications. These are marketed to industrial health physicians and medical clinics.
Mesa Pharmacy has developed a series of topical creams, in different strengths. The transdermal creams are tailored to patients suffering from long-term pain associated with work place related injuries. Praxsyn, through Mesa Pharmacy, provides a series of formulations that are compounded by using Food and Drug Administration (FDA) approved pain medication formulations to help patients suffering from pain associated with injuries. Via compounding, a patient can receive medication precisely formulated for his or her needs and medical history.
Praxsyn’s NexGen Med Solutions is a billing and collections company. NexGen established to enable Praxsyn to manage its accounts receivables in a more cost-effective and efficient manner. The expectation is that this new subsidiary will provide an integrated alternative to prior billing and collections procedures.
Praxsyn has begun to process Preferred Provider Organization (PPO) prescriptions. Mesa Pharmacy’s commitment is to providing medical practitioners with medications for patients through this move into the PPO network with its new and advanced products. Mesa has now expanded its inventive and non-addictive product line beyond topical creams to also include capsules, patches, and shampoos.
In June, Praxsyn’s wholly-owned subsidiary, Mesa Pharmacy, announced that on June 9, 2015, it executed a new Services Agreement with NHS Pharma Sales, Inc. (NHS). Through its relationship with NHS, Mesa Pharmacy's revenue has grown considerably over the past six months. NHS is building on its mutually beneficial relationship and taking on a more active role in its affiliation with Mesa Pharmacy.
Praxsyn Corp. (PXYN), closed Tuesday's trading session at $0.023, up 9.52%, on 2,027,992 volume with 43 trades. The average volume for the last 60 days is 1,353,943 and the stock's 52-week low/high is $0.0071/$0.0995.
Xenonics Holdings, Inc. (XNNH)
PennyStocks24, Bull Trends, Club Penny Stocks Network, PennyStockScholar, Stock Rich, Cool PennyStocks, BullRally, and Stockpalooza reported earlier on Xenonics Holdings, Inc. (XNNH), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Xenonics Holdings, Inc. develops and produces advanced, lightweight, and compact ultra-high-intensity illumination and low-light vision products. These products are for military, law enforcement, public safety, and also private sector and commercial applications. The Company employs patented technologies. Xenonics provides unique solutions for customers who must see farther so they can do their jobs better and safer. Xenonics Holdings is based in Carlsbad, California. The Company’s shares trade on the OTCQB.
Xenonics’ illumination engine delivers tightly focused, ultra-high intensity beams of visible or infrared light (and also ultraviolet). In addition, the Company’s technology produces a beam without the "black hole" that is characteristic of other illumination products.
Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces. This line is also used by law enforcement and security agencies. NightHunters provide unique capabilities that allow users to see first and act first, with the versatility to quickly adapt to and dominate changing conditions at night. The NightHunter line of products consists of the NightHunterONE, NightHunter3, and the NightHunterext.
The design of Xenonics’ SuperVision high-definition night vision is for commercial and military applications. SuperVision’s performance compares to military-grade (Gen III) night vision. It provides greater resolution, better clarity, and longer range and zoom capability.
SuperVision’s patented digital technology offers a 2x to 8x zoom magnification, high resolution HDTV display, and proprietary DSP technology. SuperVision is especially designed for military, law enforcement, and security professionals and their special requirements in the dangerous international environment.
Xenonics Holdings announced in November 2014 that it was awarded a purchase order valued in excess of $300,000 for its NightHunter high-intensity illumination devices. The order was received from Aardvark Tactical, Inc. (ATI), Azusa, California, on behalf of the U.S. Marine Corps.
This past March, Xenonics announced that it was awarded purchase orders valued at $450,000 for its NightHunter high-intensity illumination devices and accessories. These orders were received from ADS, Inc., Virginia Beach, Virginia, and the Defense Logistics Agency (DLA) on behalf of the U.S. Army.
Xenonics Holdings, Inc. (XNNH), closed Tuesday's trading session at $0.1351, up 3.84%, on 154,789 volume with 26 trades. The average volume for the last 60 days is 19,147 and the stock's 52-week low/high is $0.11/$0.47.
FLASR, Inc. (FLSR)
Wall Street Mover, InvestorTrendz, Damn Good Penny Picks, Penny Stock Newsletter, PREPUMP STOCKS, Penny Picks, Whisper from Wall Street, and Otcstockexchange reported recently on FLASR, Inc. (FLSR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Established in 2012, FLASR, Inc. is a first-of-its-kind tobacco accessory producer. The Company targets moist snuff users in the U.S. It produces and sells portable tobacco flasks for tobacco and moist snuff users. The Company offers FLASR, which is a reusable portable spittoon system used chiefly to contain moist tobacco by-product. FLASR has its corporate headquarters in Atlanta, Georgia. The Company lists on the OTC Bulletin Board.
FLASR recognized the need for more discreet and convenient disposal of moist tobacco by-product. The result is its 4-oz. pocket-size, portable tobacco flask, with unique bottle designs and innovative Thumb-Lok Twist Cap. The design of FLASR is for one-handed ease of use. They are suitable for sporting events, hunting, fishing and more. The design of the portable spittoon is with male users in mind.
The product meets the untapped market for smokeless tobacco users, an alternative to traditional spittoons, which allows for more discretion and convenience. The Thumb-Lok Twist Cap is easy to open, never leaks, and prevents spills.
Numerous distribution centers across the U.S. handle the distribution and shipping for FLASR products. The Company’s immediate goal is to become the principal accessory for moist snuff users.
FLASR’s flasks, designed for smokeless tobacco users, are available for the first time in 400 stores in the U.S. The product is being marketed to retailers by Product and Service Distribution Technologies, Ltd. (PSDT). PSDT reaches 85 percent of retail outlets in the U.S.
Recently, FLASR announced that it will begin a YouTube TrueView advertising campaign to raise visibility for its product throughout the U.S. As part of this campaign, 30-second FLASR commercials will play before selected videos. In the past eight months, FLASR has announced almost a dozen major partnerships.
The Company has embarked on a multimillion-dollar media campaign. Further to its TrueView advertising campaign, FLASR has partnered with Professional Bull Riding (PBR) and Championship Bull Riding (CBR). It has also sponsored up-and-coming bull riding star Brannon Eldred, and NASCAR drivers Reed Sorenson and Ryan Sieg.
FLASR, Inc. (FLSR), closed Tuesday's trading session at $0.1401, down 6.60%, on 12,856 volume with 7 trades. The average volume for the last 60 days is 49,862 and the stock's 52-week low/high is $0.15/$0.66.
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.079, up 12.86%, on 11,368,120 volume with 909 trades. The stock’s average daily volume over the past 60 days is 4,416,743 and its 52-week low/high is $0.0035/$0.45.
Dominovas Energy Corp. announced today the establishment of critical relationships with financing partners included within the scope of the Power Africa Initiative. As a Private Sector Partner, Dominovas Energy looks forward to exercising its direct access to Power Africa's committed government, public and private sector lenders, such as Goldman Sachs, Barclays and Standard Bank, and global development finance institutions (DFIs), such as the Overseas Private Investment Corporation (OPIC) and the Africa Development Bank (AfDB).
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Establishes Relationships With Strategic Financing Partners
Dominovas Energy Lauds Scope of Power Africa Initiative
Dominovas Energy Lands Historic Partnership With U.S. Government
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $1.1032, even for the day, on 10 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,713, and its 52-week low/high is $1.00/$7.30.
Aristocrat Group Corp. flagship product RWB Ultra-Premium Handcrafted Vodka has now been approved for sale in the state of Louisiana as ASCC continues to grow its distribution network. The company announced today that the first shipment of made-in-the-USA vodka is already on its way to the Pelican State, an important market for distilled spirits - particularly because of the state’s gaming resorts and nightlife tourism.
The Aristocrat Group Corp. (ASCC) is a brand management company specializing in the discovery and promotion of unique brands with mass market appeal. The company strategizes to capitalize on unprecedented brand-building opportunities, and is working to build a portfolio of successful brands to compete alongside industry leaders like Moet Hennessy, Louis Vuitton, Diageo PLC, and Brown-Forman Corp.
Luxuria Brands, an ASCC subsidiary, is tasked with brand management and sustainability, specifically in the beverage alcohol sector, where the company will develop and market brands using strategic, cross-cultural branding initiatives that engage businesses and consumers. Vodka boasts a significantly high market share, accounting for 25 percent of all distilled spirits sold in the United States. What this means for ASCC investors is that they have a remarkable chance to capitalize on a proven commodity and business model for distribution.
To this accord, ASCC's current portfolio of premium luxury goods brands includes top-shelf distilled spirits like RWB Vodka, an ultra-premium handcrafted spirit that has already met remarkable success, including multiple awards. The market for vodka is estimated to be at almost 60 million cases per year in the United States alone, and beverages priced at a premium level are garnering top-dollar returns for businesses and investors. Strategizing to capitalize on this powerful sector, ASCC plans to debut a second lifestyle vodka brand later this year.
ASCC's experienced and visionary management team is committed to creating a solid foundation for innovative technologies and models, ranging from mobile couponing to social engagement, that drive business forward. Building on its established presence in the lucrative beverage alcohol sector, ASCC is emerging as a trusted platform where fledgling ideas turn into commercial successes. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Adds to Its Growing U.S. Distribution Network
ASCC Makes Plans to Replicate Bag-in-Box Wine’s Growth With Vodka
ASCC to Promote RWB Vodka at ‘World’s Premiere Cocktail Festival’
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0041, off by 4.65%, on 14,966,793 volume with 176 trades. The stock’s average daily volume over the past 60 days is 9,620,414, and its 52-week low/high is $0.0008/$0.0348.
One World Holdings, Inc. subsidiary The One World Doll Project announced today that the company has been featured in a July 7 New York Daily News feature article entitled, Diverse dolls like the Prettie Girls! Tween Scene help retailers like Walmart toy with change. "With media coverage from the likes of CNN, Huffington Post, USA Today and now New York Daily News, we are confident this kind of publicity will help to solidify The Prettie Girls! Tween Scene dolls as a "must have" for Christmas 2015," stated Trent T. Daniel, Founder of One World Holdings, Inc. "We believe that getting the attention of major media outlets such as The New York Daily News makes a strong statement about The Prettie Girls! potential to become a popular mainstream product," she added.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
New York Daily News Releases Feature Story on the Prettie Girls Tween Scene Dolls and the One World Doll Project
The One World Doll Project Unveils Preview of the New Prettie Girls! Tween Scene Story Book
One World Holdings, Inc. (OWOO) Announces Initial Order from Hallmark Stores
Galenfeha, Inc. (GLFH)
The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.3998, off by 7.02%, on 30,667 volume with 10 trades. The stock’s average daily volume over the past 60 days is 42,445, and its 52-week low/high is $0.1011/$4.00.
announced today that its stored energy products will be offered through ABB Group, a global leader in power and automation technologies. Galenfeha's proprietary products include the GLFH-30 LiFePO4 battery system; DLP Solar Powered Chemical Injection Pump; DLP Pneumatic Chemical Injection Pump; and the iWaV Control System. The company is based in Ft. Worth, Texas, with manufacturing and distribution facilities in Shreveport, Louisiana.
Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.
Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.
Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.
The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer
Galenfeha, Inc. Company Blog
Galenfeha, Inc. News:
Galenfeha, Inc. Products Offered by Leading Power and Automation Company
Galenfeha Stored Energy Solutions Enters Aviation Industry
Galenfeha Broadens Oil and Gas Industry Penetration
Fastfunds Financial Corp. (FFFC)
The QualityStocks Daily Newsletter would like to spotlight Fastfunds Financial Corp. (FFFC). Today, Fastfunds Financial Corp. closed trading at $0.0006, off by 14.29%, on 6,126,739 volume with 19 trades. The stock’s average daily volume over the past 60 days is 9,835,140, and its 52-week low/high is $0.0005/$0.36.
Fastfunds Financial Corp. announced today the signing of a sales representation agreement by FFFC subsidiary, Cannabis Merchant Financial Solutions, Inc. (CMFS), with Evergreen Licensing of Northridge, California (Evergreen) for the Tommy Chong Green Card. Evergreen is the exclusive distribution company in the state of California for Tommy Chong - which provides them the right to distribute and license the brand to collective operators for developing and distributing Tommy Chong branded THC based products and merchandise. Evergreen and its affiliated entities have been successful in placements to date in approximately 300 dispensaries.
Fastfunds Financial Corp. (FFFC) operates through two wholly owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, to build a portfolio of revenue-generating companies that provide ancillary services to the burgeoning cannabis industry. The company also operates majority-owned subsidiary Financiera Moderna, Inc., which offers financial services to the underserved Hispanic community. FFFC's strategy to participate in the marijuana industry is through the development of four separate business verticals for the emerging U.S. cannabis industry.
Through its 49% stake in Cannabis Merchant Financial Solutions, Inc. (CMFS), FFFC entered the Financial Service business vertical. CMFS developed the Green Card and Tommy Chong Green Card, a reloadable stored value card with a rewards feature, and the Tommy Chong Frequent Buyers Card, which functions as a gift card or rewards card. FFFC is developing a national group of master resellers, distributors and sales representatives for these card products.
As the cannabis industry continues to develop, FFFC is partaking in Plant Botany, specifically the development of methods and technologies to significantly enhance plant growth and purity. Under an operating agreement with Sanidor Systems to create Pure Grow Systems, LLC, FFFC acquired a 49% interest in the subsidiary, which is dedicated to the healthy production and processing of raw materials used for medicinal or other health related purposes.
The cannabis industry is a cash-only business, which leaves companies vulnerable to criminal activities. FFFC plans to address this issue and enter the Security Services and Equipment sector through the acquisition of an existing, operational security company. FFFC owns a 70% stake in Ohio-based Brawnstone Security, Inc., a diversified security, training and investigations company. FFFC's research shows that operating margins for cannabis-related security services could exceed current billing levels by at least 100%.
FFFC's Cannabis Angel, Inc. ("CA") subsidiary will evaluate and provide corporate development services and early seed financing for worthwhile development-stage cannabis ventures. To date, CA has made investments in companies involved in the distribution of cannabis-related products and development of a social media website. It is important to note that all of FFFCs activities in the cannabis industry are ancillary, or pick and shovel, and are evaluated to insure compliance with all state and federal Laws. Disclaimer
Fastfunds Financial Corp. Company Blog
Fastfunds Financial Corp. News:
Fastfunds Financial Corporation Announces Major Milestone for Achieving National Distribution of Tommy Green Card
Fastfunds Financial Corporation Releases Mid-Year Letter to Update Stockholders
Fastfunds Financial Corporation Reports on Attendance at the Arizona Cannabis for Wellness Festival
Today's Top 3
INO.com Market Report
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Aristocrat Group Corp. (ASCC) Adds to Its Growing U.S. Distribution Network
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Establishes Relationships With Strategic Financing Partners
- Fastfunds Financial Corp. (FFFC) Announces Major Milestone for Achieving National
- Galenfeha, Inc. (GLFH) Products Offered by Leading Power and Automation Company
- Giggles N' Hugs, Inc. (GIGL) Appears on Bloomberg via RedChip Money Report: Small Stocks Big Money
- Growblox Sciences, Inc. (GBLX) Receives Funding to Complete Construction of Nevada Cultivation Facility
- International Stem Cell Corp. (ISCO) to Present at International Society for Cellular Therapy Annual Meeting
- Loans4Less.com Inc. (LFLS) Enters into an Acquisition Agreement with 321LEND
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- On the Move Systems, Inc. (OMVS) Key Trucking Industry Survey Bolsters OMVS’s Shared Economy Model
- One World Holdings, Inc. (OWOO) New York Daily News Releases Feature Story on the Prettie Girls Tween Scene Dolls and the One World Doll Project
- Pure Hospitality Solutions, Inc. (PNOW) Releases Oveedia Site Snapshots
- View Systems, Inc. (VSYM) Files for Patent, Begins Manufacturing of Enhanced ViewScan Product
- VistaGen Therapeutics, Inc. (VSTA) Receives FDA and NIH Clearance to Initiate NIH-Funded Phase 2 Study of Orally Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- WRIT Media Group, Inc. (WRIT) Featured in Exclusive QualityStocks Production Video